01/08/2024
PrognomiQ’s Latest Research Demonstrates the Potential of its Multi-omics Liquid Biopsy Platform in Early-Stage Detection of Lung Cancer
Read More
01/23/2023
PrognomiQ’s Multi-omics Liquid Biopsy Platform Demonstrates Promising Results in Early-Stage Cancer Detection of Non-Small Cell Lung Cancer
Read More
11/29/2022
PrognomiQ Strengthens its Scientific and Clinical Leadership with the Appointment of Brian Koh, M.D. as Chief Medical Officer
Read More
06/21/2022
Maccabi’s KSM Research and Innovation Center & PrognomiQ Announce Research Collaboration Aimed at Early Cancer Detection
Read More
03/15/2022
PrognomiQ Announces $46 Million Financing to Advance Development of its Multi-omics Product Pipeline for Early Detection and Treatment of Cancer
Read MoreThe news articles below were developed independently and any commentary or opinions are those of the publication.
07/13/2023
Apparently Getting Smarter Makes Us Healthier: AI And Data Analysis Revolutionize Healthcare
Read More
January 2024
Multi-omics profiling with untargeted proteomics for blood-based early detection of lung cancer
See Publication
October 2023
Multi-omic, plasma biomarkers for non-small cell lung cancer demonstrate strong performance for early cancer detection
See Presentation
September 2023
Deep, Multiomics, Bloodbased Biomarker Discovery In Current And Former Smokers Demonstrated High Early Detection Performance…
See Poster
June 2023
timsTOF HT improves protein identification and quantitative reproducibility for deep unbiased plasma protein biomarker discovery
See Poster
June 2023
Electrospray ionization source comparison and optimization on a capillary-flow SUREQUANT assay
See Poster
June 2023
Dual-column ZenoTOF configuration to achieve robust and high-quality plasma proteomics
See Poster
June 2023
Combination of the unique functions from timsTOF and ZenoTOF enables in-depth analysis of the glycoproteome
See Poster
June 2023
Automated and scalable cloud-based computational pipeline for large-scale unbiased plasma proteomics study
See Poster
June 2023
A comprehensive strategy for building DIA library and multi-aspect comparisons on SWATH data with ZenoTOF
See Poster
May 2023
Biomarker discovery in non-small cell lung cancer enabled by deep multi‑omics profiling of proteins, metabolites,…
See Poster
May 2023
A multi-omics classifier achieves high sensitivity and specificity for Pancreatic ductal adenocarcinoma in a case-control…
See Poster
September 2022
High-Dimensional, Multi-Omics Analyses of Proteins, Metabolites, Transcripts, and Genes Enable Biomarker Discovery in Early- and…
See Poster
June 2022
Combining Proteograph technology with Zeno SWATH acquisition enables the potential for deep, unbiased discovery of…
See Poster
June 2022
An unbiased multi-omics approach for the detection of pancreatic cancer biomarkers utilizing ion-mobility mass spectrometry…
See Poster
April 2022
Deep, unbiased multi-omics approach for identification of pancreatic cancer biomarkers from blood
See Poster
March 2022
Incorporation of glycoproteome detection into large scale unbiased proteomics studies utilizing nanoparticles
See Poster
November 2021
Large scale, deep, and unbiased proteomics profiling a sub-study of a multi-cancer cohort enabling biomarker…
See Poster
